Epileptik Nöbete ve Status Epileptikusa Yaklaşım
Özet
Epileptik nöbetler ve status epileptikus (SE), beyindeki anormal elektriksel deşarjlar ve senkron nöronal aktivite sonucu ortaya çıkan, acil müdahale gerektiren kritik nörolojik durumlardır. Klinik yaklaşımda nöbetin ilk 5 dakikası başlangıç tedavisi (T1), 30 dakika ve sonrası ise kalıcı beyin hasarı riski (T2) açısından kritik süreler olarak kabul edilir. ILAE 2017 standartlarına göre SE sınıflandırması semiyoloji, etiyoloji, yaş ve EEG bulguları olmak üzere dört eksende yapılır. Tedavi süreci; erken evre, yerleşmiş SE, refrakter SE ve süper refrakter SE olarak dört aşamada yönetilir. İlk basamak tedavide lorazepam, diazepam ve midazolam gibi benzodiazepinler tercih edilirken; benzodiazepine dirençli yerleşmiş SE aşamasında valproik asit, levetirasetam ve fenitoin/fosfenitoin gibi sedatif olmayan antiepileptik ilaçlar devreye girer. Ağır sedatif ajanlara da yanıt vermeyen dirençli olgularda ise propofol, barbitüratlar, terapötik hipotermi ve ketojenik diyet gibi agresif ve alternatif yöntemler uygulanır. Süreç yönetiminde ayrıca preeklampsi/eklampsi nöbetlerinde magnezyum sülfat kullanımı, çocukluk çağı febril konvülsiyonları ve nöbet sonrası geçici felç durumu olan Todd paralizisinin ayırıcı tanısı hayati önem taşır. Zamanında yapılan multidisipliner müdahaleler, mortalite oranlarını düşürmede ve hastanın prognozunu iyileştirmede en belirleyici faktördür.
Epileptic seizures and status epilepticus (SE) are critical neurological conditions requiring emergency intervention, arising from abnormal electrical discharges and synchronous neuronal activity in the brain. In clinical management, the first 5 minutes of a seizure are recognized as the threshold for initiating treatment (T1), whereas durations of 30 minutes or longer represent a critical timeframe for permanent brain injury risk (T2). According to ILAE 2017 standards, SE classification is evaluated across four axes: semiology, etiology, age, and EEG correlation. The therapeutic process is managed in four distinct chronological stages: early stage, established SE, refractory SE, and super-refractory SE. Benzodiazepines such as lorazepam, diazepam, and midazolam are preferred as first-line treatment; however, in the benzodiazepine-resistant established SE phase, non-sedative antiepileptic drugs including valproic acid, levetiracetam, and phenytoin/fosphénytoin are utilized. For refractory cases non-responsive to heavy sedatives, aggressive and alternative methods such as propofol, barbiturates, therapeutic hypothermia, and ketogenic diets are implemented. Furthermore, the management process highlights the utilization of magnesium sulfate in preeclampsia/eclampsia seizures, the evaluation of childhood febrile convulsions, and the differential diagnosis of Todd's paralysis, which causes transient postictal paralysis. Timely and multidisciplinary interventions remain the most decisive factors in lowering mortality rates and significantly optimizing patient prognosis.
Referanslar
Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International Leageue Against Epilepsia(ILAE) and the International Bureau for Epilpesi(IBE). Jr. Epilepsia.2005 Apr;46(4):470-2.)
Pitkänen A, Lukasiuk K, Dudek FE, et al . Epileptogenesis. Cold Spring Harbor Perspectives in Medicine2015;18:5(10). pii: a022822
Vezzani A, Fujinami RS, White HS, et al. Infections, inflammation and epilepsy. Acta Neuropathologica2016;131(2):211-34.
Lukasiuk K, Becker AJ.Molecular biomarkers of epileptogenesis. Neurotherapeutics 2014; 11:319-23.)
Blumcke, et al. Histopathological Findings in Brain Tissue Obtained during Epilepsy SurgeryIngmar. New England Journal of Medicine . 2017.
Thom M, Sisodiya S. Epilepsy. In: Greenfield's Neuropathology. Vol 1. In: Love S, Budka H. Ironside JW, Perry A, eds. 9th ed. London, New York: CRC Press; 2015. p.683-739.
Blümcke I, Coras R. International Summer School for Neuropathology and Epilepsy Surgery INES 2014
Epilepside Genetik Bebek N, Şahin E, Türkiye kliniklericilt 10 sayı 1 yıl 2017 sayfa 11-16)
VarnadoS, PriceD. Basics of modern epilepsy classification and terminology PMID: 33153903DOI: 10.1016/j.cppeds.2020.1008912020 Nov;50(11):100891.doi: 10.1016/j.cppeds.2020.100891. Epub 2020 Nov 3.
S Benbadis. The differential diagnosis of epilepsy: a critical reviewEpilepsy& Behavior. 2009 May;15(1):15-21. doi: 10.1016/j.yebeh.2009.02.024. Epub 2009 Feb 21.
Baburoğlu M , SencerN.S., Nörogörüntüleme. Turkiye Klinikleri J Neurol-Special Topics. 2017;10(1):45-8
5. Gaillard WD, Chiron C, Cross JH, et al. ILAE, Committee for Neuroimaging, Subcommittee for Pediatric. Guidelines for imaging infants and children with recent-onset epilepsy. Epilepsia 2009;50(9):2147-53.
KantiRoy M, Gupta RD, Kolkata. Usefulness and limitation of neuroimaging in epilepsy. Medicine Update 2010;20:740-3.
Bora , Yeni SN. Anormal EEG Bulguları EEG Atlasi.1. baskı, İstanbul: Nobel Tip KitapEvleri Ltd. Şti; 2012. p.201-22,
Emre M (ç. ed.), Epilepsi ve Bilinç Bozukluları.Adams and Victor's Principles of Neurology 9. Baskısayfa 303-339, 2013
Panayiotopoulos CP. The Epilepsies: Seizures, Syndromesand Management. Brain Imaging in the Diagnosis and Management of Epilepsies Chapter 3. Oxfrodshire (UK): Bladon Medical Publishing; 2005.
Fisher RS, Acevedo C. Arzimanolou A, et al. A practical clinical definition of epilepsy.Epilepsia. 2014;55(4):475-82.
Herman, ST. Single Unprovoked Seizures. Current Treatment Options in Neurology. 2004,6(3):243-255. doi: 10.1007/s11940-004-0016-5.
Sethi N.K. , Shinnar S. Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015 Oct 27;85(17):1525.doi: 10.1212/WNL.0000000000002093.
Ascoli M, Ferlazzo E, Gasparini S, et al.Epidemiology and Outcomes of Status EpilepticusReview International Journal of General Medicine 2021 Jun 28;14:2965-2973. doi: 10.2147/IJGM.S295855. eCollection 2021. PMID: 34234526 PMCID: PMC8254099 DOI: 10.2147/IJGM.S295855
Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Currents. 2016;16:48–61
Alkhachroum A, Der-nigoghossian CA, Rubinos C, et al. Markers in status epilepticus prognosis. Journal of Clinical Neurophysiology. 2020;37(5):422–428. doi:10.1097/WNP.0000000000000761
Nelson SE, Varelas PN. Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus Continuum Lifelong Learn Neurology. 2018;24(6):1683-1707. doi:10.1212/CON.0000000000000668
Jagoda, A Riggio, S. Refractory status epilepticus in adults. Annals of Emergency Medicine 1993; 22: 1337–1348.
Yechoor N, Adeli A, Hafeez S. External validation of the epidemiology based mortality score in status epilepticus in an American intensive care population. Epilepsy Res. 2018;148:32–36. doi:10.1016/j.eplepsyres.2018.10.001
TrinkaE, CockH, HesdorfferD, et al. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus PMID: 26336950 DOI: 10.1111/epi.13121
Zehtabchi S, Silbergleit R, Chamberlain J.M, et al. Electroencephalographic Seizures in Emergency Department Patients After Treatment for Convulsive Status EpilepticusPMID: 33337664, PMCID: PMC8192587 (available on 2022-06-11), DOI: 10.1097/WNP.0000000000000800
Glauser T, Shinnar S,Gloss D, Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society First Published January 1, 2016
Vossler D.G, Bainbridge J.L, Boggs J.G, Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee First Published August 21, 2020 Research Article
Trinka E, Höfler J, Leitinger M ,et al. Pharmacotherapy for Status Epilepticus. Drugs volume 75, pages1499–1521 (2015)
Jones S, Pahl C, Trinka E, et al. A protocol for the inhospital emergency drug management of convulsive status epilepticus in adults. Practical Neurology. 2014;14(3):194–7.
Trinka E. Benzodiazepines used primarily for emergency treatment (diazepam, lorazepam, and midazolam).Treatment of epilepsies In: Shorvon SD, Perucca E, Engel Jr J, editors. 3rd ed. Oxford: Blackwell Publishing; 2009. p. 470–84
Chamberlain JM, Okada P, Holsti M, et al. Lorazepam vs diazepam for pediatric status epilepticus: A randomized clinical trial. JAMA. 2014;311(16):1652–60
KobataH, HifumiT, HoshiyamaE, et al. Comparison of diazepam and lorazepam for the emergency treatment of adult status epilepticus: a systemic review and meta-analysisJapan Resuscitation Council (JRC) Neuroresuscitation Task Force and the Guidelines Editorial CommitteeAffiliations expand PMID: 33489240 PMCID: PMC7809602 DOI: 10.1002/ams2.582
Alldredge BK, Gelb AM, Isaacs SM, et al. Comparison of lorazepam, diazepam and placebo in the treatment of out-of-hospital status epilepticus. The New England Journal of Medicine. 2001; 345 :631–7. [Erratum, N Engl J Med 2001;345:1860.]
Prasad K, Krishnan PR, Al Roomi K, et al. Anticonvulsant therapy for status epilepticusBritish Journal of Clinical Pharmacology. 2007;63(6):640–7.
Prasad M, Krishnan PR, Sequeira R, et al. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev2014;9:CD003723.
Cereghino JJ, Cloyd JC, Kuzniecky RI. Rectal diazepam gel for treatment of acute repetitive seizures in adults. Archives of Neurology. 2002;59(12):1915–20.
Remy C, Jourdil N, Villemain D, et al. Intrarectal diazepam in epileptic adults. Epilepsia. 1992;33(2):353–8.
Basit H, Kahwaji CI. Clonazepam In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.2021 Apr 29. Affiliations expand PMID: 32310470 Bookshelf ID: NBK556010
Congdon PJ, Forysthe WI. Intravenous clonazepam for the treatment of status epilepticus in children. Epilepsy. 1980;21:97–102.
Singh AN, Le Morvan P. Treatment of status epilepticus with intravenous clonazepam. Progress in Neuro-Psychopharmacology & Biological Psychiatry 1982;6(4–6):539–42.
Navarro V, Dagron C, Elie C, et al. Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial.Lancet Neurology. 2016 Jan;15(1):47-55. doi: 10.1016/S1474-4422(15)00296-3. Epub 2015 Nov 28.PMID: 26627366 Clinical Trial.
Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. The New England journal of medicine. 2012;366(7):591–600.
Lahat E, Goldman M, Barr J, et al. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. The British Medical Journal. 2000;321(7253):83–6.
Mahmoudian T, Zadeh MM. Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children. Epilepsy & Behavior. 2004;5(2):253–5.
Thakker A, Shanbag P. A randomized controlled trial of intranasal-midazolam versus intravenous-diazepam for acute childhood seizures. Journal of Neurology. 2013;260(2):470–4
McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005;366(9481):205–10.
Talukdar B, Chakrabarty B. Efficacy of buccal midazolam compared to intravenous diazepam in controlling convulsions in children: a randomized controlled trial. Brain & Development.2009;31(10):744–9.
Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet. 1999;353(9153):623–6.
Shah I, Deshmukh CT. Intramuscular midazolam vs intravenous diazepam for acute seizures. Indian Journal of Pediatrics . 2005;72(8):667–70.
Cranford RE, Leppik IE, Patrick B, et al. Intravenous phenytoin in acute treatment of seizures. Neurology. 1979;29(11):1474–9
Dalziel S.R, BorlandM.L, FurykJ, Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.Lancet. 2019 May 25;393(10186):2135-2145. doi: 10.1016/S0140-6736(19)30722-6. Epub 2019 Apr 7.PREDICT research network
J. M, KapurJ, Shinnar S, et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial ChamberlainNeurological Emergencies Treatment Trials; Pediatric Emergency Care Applied Research Network investigators. Lancet. 2019 May 25;393(10186):2135-2145. doi: 10.1016/S0140-6736(19)30722-6. Epub 2019 Apr 17PMID: 32203691 PMCID: PMC7241415 DOI: 10.1016/S0140-6736(20)30611-5
Burneo JG, Anandan JV, Barkley GL. A prospective study of the incidence of the purple glove syndrome. Epilepsia. 2001;42(9):1156–9.
O’Brien TJ, Cascino GD, So EL, et al. Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. Neurology. 1998;51(4):1034–9.
Chhabra P, Gupta N, Kaushik A. Compartment syndrome as a spectrum of purple glove syndrome following intravenous phenytoin administration in a young male: A case report and review of literature. Neurology India. 2013;61(4):419–20.
Ramsay RE, Wilder BJ, Uthman BM, et al. Intramuscular fosphenytoin (cerebyx) in patients requiring a loading dose of phenytoin. Epilepsy Research. 1997;28(3):181–7.
Wilder BJ, Campbell K, Ramsay RE, et al. Safety and tolerance of multiple doses of intramuscular fosphenytoin substituted for oral phenytoin in epilepsy or neurosurgery. Archives of Neurology. 1996;53(8):764–8.
Emilio Perucca. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience PMID: 12269862DOI: 10.2165/00023210-200216100-00004 2002;16(10):695-714 .
Limdi NA, Knowlton RK, Cofield SS, et al. Safety of rapid intravenous loading of valproate. Epilepsia. 2007 Mar; 48(3):478-83.
Trinka E, Höfler J, Zerbs A, et al. Efficacy and safety of intravenous valproate for status epilepticus: a systematic review. CNS Drugs 2014;28:623–639.
Agarwal P, Kumar N, Chandra R, et al. Randomized study of intravenous valproate and phenytoin in status epilepticus.Seizure. 2007 Sep; 16(6):527-32.
Patsalos P.N. Clinical pharmacokinetics of levetiracetam 2004;43(11):707-24.doi: 10.2165/00003088-200443110-00002.
Isguder, R, Guzel, O, Ceylan, et al. A comparison of intravenous levetiracetam and valproate for the treatment of refractory status epilepticus in children. Journal of Child Neurology. 2016;31(9):1120–1126.
Moddel, G, Bunten, S, Dobis C, et al. Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus. Journal of Neurology, Neurosurgery and Psychiatry. 2009;80(6):689–692.
Trinka E, Dobesberger J. New treatment options in status epilepticus: a critical review on levetiracetam. Therapeutic Advances in Neurological Disorders. 2009;2(2):79–91.
Zelano J, Kumlien E. Levetiracetam as alternative stage two antiepileptic drug in status epilepticus: a systematic review. Seizure. 2012;21(4):233–6.
Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure 2014;23(3):167–74.
Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocritical Care.2012;17:3–23.
Haller J.T, Bonnin S , Radosevich J. Rapid administration of undiluted intravenous levetiracetam 2021 Aug;62(8):1865-1870. doi: 10.1111/epi.16961. Epub 2021 Jun 24.PMID: 34164804DOI: 10.1111/epi.16961
Beyreuther BK, Heers C, Krebsfanger N, et al. Lacosamide: a review of preclinical properties. CNS Drug Review 13:21-42. (2007)
Santamarina E, Toledo M, Sueiras M, et al. Usefulness of intravenous lacosamide in status epilepticus. Journal of Neurology 2013; 260: 3122–3128.
Höfler J, Trinka E. Lacosamide as a new treatment option in status epilepticus. Epilepsia. 2013 Mar; 54(3):393-404.
Krause LU, Brodowski KO, Kellinghaus C. Atrioventricular block following lacosamide intoxication. Epilepsy & Behavior. 2011 Apr; 20(4):725-7
Rai S and DrislaneF.W.Treatment of Refractory and Super-refractory Status Epilepticus. 2018 Jul; 15(3): 697–712.Published online 2018 Jun 19. doi: 10.1007/s13311-018-0640-5
Hocker S. Treatment of refractory and super-refractory status epilepticus. Status epilepticus. A clinical perspective. Chap 17. In: Drislane FW, Kaplan PW, editors. 2. Cham: Humana Press; 2017. pp. 201–214.
Rossetti AO, Reichhart MD, Schaller MD, et al. Treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia. 2004;45:757–763. doi: 10.1111/j.0013-9580.2004.01904.x.
Pugin D, Foreman B, De Marchis GM, et al. Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study. Critical Care 2014;18:R103
Lee S.K. Diagnosis and Treatment of Status Epilepticus. Korea Journal of Epilepsy Research 2020; 10(2): 45-54. Published online: December 31, 2020 DOI: https://doi.org/10.14581/jer.20008
Ferlisi M, Hocker S, Grade M, et al. Preliminary results of global audit of refractory status epilepticus treatment of step IS. Epilepsy Behavior. 2015; 49 :318–324. doi: 10.1016/j.yebeh.2015.04.010.
Shorvon S, Baulac M, Cross H, et al.The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia. 2008; 49 :1277–1285. doi: 10.1111/j.1528-1167.2007.01478.x
Claassen J, Hirsch L.J, Emerson R.G, et al. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002; 43 :146–153. doi: 10.1046/j.1528-1157.2002.28501.x.
Sokic D.V, Jankovic S.M, Vojvodic N.M, et al. Etiology of a short-term mortality in the group of 750 patients with 920 episodes of status epilepticus within a period of 10 years (1988–1997). Seizure 2009;18:215–219.
Sutter R, Marsch S, Fuhr P, et al. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology 2014;82:656–664.
Shank RP, Gardocki JF, Streeter AJ, et al.An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action.Epilepsia. 2000; 41(S1):3-9.
Towne AR, Garnett LK, Waterhouse EJ, et al. The use of topiramate in refractory status epilepticus. Neurology. 2003 Jan 28; 60(2):332-4.
Synowiec AS, Yandora KA, Yenugadhati V, et al.The efficacy of topiramate in adult refractory status epilepticus: experience of a tertiary care center.Epilepsy Research. 2012 Feb;98(2-3):232-7. doi: 10.1016/j.eplepsyres.2011.09.017. Epub 2011 Oct 15. Epilepsy Res. 2012. PMID: 22000869
Patel V, Cordato DJ, Malkan A, et al. Rectal carbamazepine as effective long-acting treatment after cluster seizures and status epilepticus. Epilepsy & Behavior 2014;31:31–33.
Dubey D, Kalita J, Misra UK. Status epilepticus: refractory and super-refractory. Neurology India. 2017;65(7):12. doi:10.4103/neuroindia.NI_958_16
Arayakarnkul P, Chomtho K. Treatment options in pediatric super-refractory status epilepticus. Brain and Development . 2019;41(4):359–366. doi:10.1016/j.braindev.2018.11.011
Hocker S, Nagarajan E, Rabinstein AA, et al. Progressive brain atrophy in super-refractory status epilepticus. JAMA Neurology. 2016;73(10):1201–1207. doi:10.1001/jamaneurol.2016.157
Ochoa JG, Dougherty M, Papanastassiou A, et al. Treatment of Super-Refractory Status Epilepticus: A Review.Epilepsy Currents. 2021 Mar 10:1535759721999670. doi: 10.1177/1535759721999670. Online ahead of print. Epilepsy Curr. 2021. PMID: 33719651
Motamedi GK, Lesser RP, Vicini S. Therapeutic brain hypothermia, its mechanisms of action, and its prospects as a treatment for epilepsy. Epilepsia. 2013;54(6):959–970. doi:10.1111/epi.12144
Juge N, Gray JA, Omote H, et al. Metabolic control of vesicular glutamate transport and release. Neuron. 2010;68(1):99–112. doi:10.1016/j.neuron.2010.09.002
Dupuis N, Curatolo N, Benoist J.F, et al. Ketogenic diet exhibits anti-inflammatory properties. Epilepsia. 2015;56(7):e95–98. doi:10.1111/epi.13038
Yamamoto H, Aihara M, Niijima S, et al. Treatments with midazolam and lidocaine for status epilepticus in neonates. Brain and Development. 2007;29(9):559–564. doi:10.1016/j.braindev.2007.02.003
Bien CG, Holtkamp M Autoimmune Epilepsy": Encephalitis With Autoantibodies for Epileptologists.Epilepsy Currents. 2017 May-Jun; 17(3):134-141.
Brenner RP. EEG in convulsive and nonconvulsive status epilepticus. Journal of Clinical Neurophysiology 21: 319– 331. (2004)
CascinoG.D. Nonconvulsive Status Epilepticus in Adults and Children,First published: January 1993https://doi.org/10.1111/j.1528-1157.1993.tb05903.xCitations: 68.
Uysal U, Quigg M, Bittel B, et al.ntravenous anesthesia in treatment of nonconvulsive status epilepticus: Characteristics and outcomes. Epilepsy Research. 2015 Oct;116:86-92. doi: 10.1016/j.eplepsyres.2015.07.005. Epub 2015 Jul 26. Epilepsy Res. 2015. PMID: 26280805 Free PMC article.
Kubota Y, Nakamoto H, Egawa S, et al. Continuous EEG monitoring in ICU. Journal of Intensive Care2018;6:1–8. 10.1186/s40560-018-0310-z –
Bauer G, Trinka E. Nonconvulsive status epilepticus and coma. Epilepsia 51: 177– 190.Wiley Online Library(2010)
Sutter R, Kaplan PW. Electroencephalographic criteria for nonconvulsive status epilepticus: synopsis and comprehensive survey. Epilepsia 53(Suppl. 3): 1– 51(2012)
ThomasP, ValtonL, Genton P.Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain. Volume 129, Issue 5, May 2006, Pages 1281–1292, https://doi.org/10.1093/brain/awl047
ShorvonS, BaulacM,CrossH, et al. The drug treatment of status epilepticus in Europe: Consensus document from a workshop at the first London Colloquium on Status Epilepticus,for the TaskForce on Status Epilepticus of the ILAECommission for European Affairs.Epilepsia.First published: 04 July 2008https://doi.org/10.1111/j.1528-1167.2008.01706_3.x
Khan Z, Arya K, Bollu PC.Epilepsia Partialis Continua.2021 Sep 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–.PMID: 30335308
Shorvon S, Baulac M, Cross H, et al. The drug treatment of status epilepticus in europe: Consensus document from a workshop at the first london colloquium on status epilepticus. Epilepsia. 2008;49(7):1277–85.
Serafini A, Gerard EE, Schuele SU. Myoclonic status epilepticus., editors. Status epilepticus. A clinical perspective. Chap 12. In: Drislane FW, Kaplan PW 2. Cham: Humana Press; 2017. pp. 139–153.
Wilkerson RG, Ogunbodede AC. Hypertensive Disorders of Pregnancy. Emergency Medicine Clinics of North America . 2019 May;37(2):301-316.
Sutton ALM, Harper LM, Tita ATN. Hypertensive Disorders in Pregnancy. Obstetrics and Gynecology Clinics of North America. 2018 Haz; 45 (2):333-347.
Magley M, Hinson M.R. Eclampsia Last Update: June 12, 2021.
Gill P, Tamirisa A.P, Van HookJ.W. Acute Eclampsia Last Update: July 19, 2021.
Sesar A, Cavar I, Sesar AP, et al. Transient cortical blindness in posterior reversible encephalopathy syndrome after postpartum eclampsia. Taiwan Journal of Ophthalmology. 2018 Nisan-Haziran; 8 (2):111-114.
PattersonJ.L, CarapetianS.A, HagemanJ.R, Febrile seizures. Pediatric Annals2013 Dec;42(12):249-54.doi: 10.3928/00904481-20131122-09.
LeungA.K, HonK.L, LeungT.Nh.Febrile seizures: an overview 2018 Jul 16;7:212536. doi: 10.7573/dic.212536. eCollection 2018.PMID: 30038660PMCID: PMC6052913DOI: 10.7573/dic.212536.
Sadleir LG, Scheffer I.E. Febrile seizures.British Medical Journal 2007 Feb 10; 334(7588):307-11.FC,
Tu YF, Lin CL, Lin CH, et al. Febrile convulsions increase risk of Tourette syndrome.Seizure. 2014 Sep; 23(8):651-6.
Xixis KL, Samanta D, Keenaghan M. Febrile Seizure Author InformationLast Update: July 6, 2021.
Laino D, Mencaroni E, Esposito S.Management of Pediatric Febrile Seizures 2018 Oct; 15(10): 2232.Published online 2018 Oct 12. doi: 10.3390/ijerph15102232. PMCID: PMC6210946PMID: 30321985
Subcommittee on Febrile Seizures; American Academy of Pediatrics.Clinical pratictice guideline-febrile seizures: guideline for the neurodiagnostic evaluation of the child with a simple febrile seizures. Pediatrics.2011;127:389-94.
Steering Committee on Quality Improvement and Management, Subcommittee on Febrile Seizures American Academy of PediatricsFebrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures.Pediatrics. 2008 Jun; 121(6):1281-6
Mewasingh LD Febrile seizures.British Medical JournalClin Evid. 2014 Jan 31; 2014():
Xu SY, Li ZX, Wu XW, et al. Frequency and Pathophysiology of Post-Seizure Todd's Paralysis.Medical Science Monitor. 2020 Mar 5;26:e920751. doi: 10.12659/MSM.920751.PMID: 32134903
Werhahn KJ. Weakness and focal sensory deficits in the postictal state. Epilepsy & Behavior. 2010 Oct; 19(2):138-9.
